General Information of Drug (ID: DMYATB5)

Drug Name
PMID29671355-Compound-38a
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 316.36
Logarithm of the Partition Coefficient (xlogp) 0.4
Rotatable Bond Count (rotbonds) 9
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 7
Chemical Identifiers
Formula
C15H20N6O2
IUPAC Name
N-hydroxy-7-[pyrazin-2-yl(pyrimidin-5-yl)amino]heptanamide
Canonical SMILES
C1=CN=C(C=N1)N(CCCCCCC(=O)NO)C2=CN=CN=C2
InChI
InChI=1S/C15H20N6O2/c22-15(20-23)5-3-1-2-4-8-21(13-9-17-12-18-10-13)14-11-16-6-7-19-14/h6-7,9-12,23H,1-5,8H2,(H,20,22)
InChIKey
SQFSXNZGZJNPJZ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
121304883
TTD ID
D0JR9L

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase 1 (HDAC1) TT6R7JZ HDAC1_HUMAN Inhibitor [1]
Histone deacetylase 6 (HDAC6) TT5ZKDI HDAC6_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Histone deacetylase 1 (HDAC1) DTT HDAC1 1.54E-06 0.66 4.44
Histone deacetylase 6 (HDAC6) DTT HDAC6 6.91E-02 0.27 0.79
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.